ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 22.95 TWD Market Closed
Market Cap: 18.1B TWD

Intrinsic Value

The intrinsic value of one ScinoPharm Taiwan Ltd stock under the Base Case scenario is 18.49 TWD. Compared to the current market price of 22.95 TWD, ScinoPharm Taiwan Ltd is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
18.49 TWD
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ScinoPharm Taiwan Ltd

ScinoPharm Taiwan Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ScinoPharm Taiwan Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

ScinoPharm Taiwan Ltd
TWSE:1789
TW
Pharmaceuticals
Market Cap
18.1B TWD
IPO
Oct 29, 2010
TW
Pharmaceuticals
Market Cap
18.1B TWD
IPO
Oct 29, 2010
Price
NT$false
EPS
NT$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ScinoPharm Taiwan Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ScinoPharm Taiwan Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ScinoPharm Taiwan Ltd

Current Assets 6.7B
Cash & Short-Term Investments 4.2B
Receivables 494.2m
Other Current Assets 2B
Non-Current Assets 5.3B
Long-Term Investments 80.3m
PP&E 4.6B
Intangibles 18.3m
Other Non-Current Assets 634.9m
Efficiency

Free Cash Flow Analysis
ScinoPharm Taiwan Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ScinoPharm Taiwan Ltd

Revenue
3.5B TWD
Cost of Revenue
-2.1B TWD
Gross Profit
1.4B TWD
Operating Expenses
-934.3m TWD
Operating Income
446.4m TWD
Other Expenses
-47m TWD
Net Income
399.4m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

ScinoPharm Taiwan Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
51/100
Profitability
Score

ScinoPharm Taiwan Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ScinoPharm Taiwan Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

ScinoPharm Taiwan Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ScinoPharm Taiwan Ltd

There are no price targets for ScinoPharm Taiwan Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ScinoPharm Taiwan Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one ScinoPharm Taiwan Ltd stock?

The intrinsic value of one ScinoPharm Taiwan Ltd stock under the Base Case scenario is 18.49 TWD.

Is ScinoPharm Taiwan Ltd stock undervalued or overvalued?

Compared to the current market price of 22.95 TWD, ScinoPharm Taiwan Ltd is Overvalued by 19%.

Back to Top